Key points are not available for this paper at this time.
Donor-specific HLA antibodies (DSA) has been associated with an increased risk of rejection and poorer graft outcomes.Short-term survival following desensitization has been demonstrated with acceptable outcomes.The mediumterm graft survival in Uruguay has not been studied. The objective is analyze the impact of pre-existing DSA in renal transplantation (RT) on medium-term graft survival (SV) and in the incidence of acute rejection (AR).
ACOSTA et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: